Total regression of hepatocellular carcinoma bone metastases, after liver transplantation, with sorafenib-everolimus

Abstract

Hepatocellular carcinoma (HCC) represents the 5th commonest malignancy worldwide. Liver transplantation consist a radical and most efficient treatment for HCC. Tumor recurrence or metastases after liver transplantation is not uncommon. Hereby is presented a case of a patient transplanted for alcoholic liver disease and HCC and presented with bone metastases a few months later. Treatment with sorafenib and everolimus showed full regression of the metastases. In conclusion, the point of this report is to advertise a single case of total regression of bone lesions due to HCC recurrence, with the combination of mammalian target of rapamycin and sorafenib, along with radiation.

Keywords

Liver transplantation / hepatocellular carcinoma / bone metastases / sorafenib / everolimus

References

[1] El-Serag HB,Petersen NJ.The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update..Ann Intern Med2003;139:817-23

[2] Mazzaferro V,Doci R,Pulvirenti A,Montalto F,Morabito A.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis..N Engl J Med1996;334:693-9

[3] European Association for Study of Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma..Eur J Cancer2012;48:599-641

[4] Llovet JM,Mazzaferro V,Gane E,de Oliveira AC,Raoul JL,Schwartz M,Zeuzem S,Greten TF,Seitz JF,Häussinger D,Shan M,Voliotis D.Sorafenib in advanced hepatocellular carcinoma..N Engl J Med2008;359:378-90

[5] De'Angelis N,Carra MC.Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review..World J Gastroenterol2015;21:11185-98 PMCID:PMC4607916

[6] Toso C,Majno P.Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence..J Hepatol2013;59:3-5

[7] Mazzola A,Petta S,Raineri M,Brancatelli G,Cabibbo G.Recurrence of hepatocellular carcinoma after liver transplantation: an update..Future Oncol2015;11:2923-36

[8] Zavaglia C,Mancuso A,Viganò R,Gentiluomo M.Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature..Eur J Gastroenterol Hepatol2013;25:180-6

[9] Seong J,Park HC.Radiotherapy for painful bone metastases from hepatocellular carcinoma..Liver Int2005;25:261-5

[10] He J,Fan J,Sun J,Yang P,Zhang BH.Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation..BMC Cancer2011;11:492 PMCID:PMC3298548